Feature Channels: Digestive Disorders

Filters close

Not for public release

This news release is embargoed until 6-Nov-2023 5:00 PM EST Released to reporters: 31-Oct-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 30-Oct-2023 3:05 PM EDT
Can personalized care prevent over screening for colorectal cancer in older adults?
Michigan Medicine - University of Michigan

Study reveals presenting adults between 76 and 85 with personalized information about the benefits and harms of colon cancer screening decreases excess screening

Released: 27-Oct-2023 5:05 PM EDT
The Threat of Cholera in Africa
Compuscript Ltd

Announcing a new article publication for Zoonoses journal. A multi-country cholera outbreak has occurred in several developing countries in Africa, Asia and Oceania since mid-2021.

Newswise: Chula’s Faculty of Allied Health Sciences Promotes “46 Recipes  
to Train Swallowing” in Elderly and Troubled Patients
Released: 27-Oct-2023 8:55 AM EDT
Chula’s Faculty of Allied Health Sciences Promotes “46 Recipes to Train Swallowing” in Elderly and Troubled Patients
Chulalongkorn University

A lecturer from the Faculty of Allied Health Sciences, Chulalongkorn University in collaboration with the Thai Dietetic Association, has developed 46 nutritious recipes for swallowing training in the elderly, and patients with difficulty swallowing based on recommendations of The International Dysphagia Diet Standardization (IDDSI).

Released: 27-Oct-2023 8:30 AM EDT
FDA Approves Mirikizumab, a Promising Induction and Maintenance Therapy for Ulcerative Colitis
Mount Sinai Health System

Offers new option with improved quality of life for patients with moderate-to-severely active disease.

Newswise: Dr. Jonathan Leighton Elected President of the American College of Gastroenterology
17-Oct-2023 9:00 AM EDT
Dr. Jonathan Leighton Elected President of the American College of Gastroenterology
American College of Gastroenterology (ACG)

Gastroenterologist Jonathan A. Leighton, MD, FACG, was elected by the membership as the 2023–2024 President of the American College of Gastroenterology (ACG).

Newswise: New Clinical Advances in Gastroenterology Presented at the American College of Gastroenterology’s 88th Annual Scientific Meeting
17-Oct-2023 9:00 AM EDT
New Clinical Advances in Gastroenterology Presented at the American College of Gastroenterology’s 88th Annual Scientific Meeting
American College of Gastroenterology (ACG)

Featured science includes the reliability of AI-generated clinical information, diet and GI disease risk, innovative approaches to inflammatory bowel disease monitoring, women’s health, and more.

Newswise: Featured Lectures at the 2023 ACG Annual Scientific Meeting and Postgraduate Course
17-Oct-2023 9:00 AM EDT
Featured Lectures at the 2023 ACG Annual Scientific Meeting and Postgraduate Course
American College of Gastroenterology (ACG)

This year’s lectures highlight changing populations in liver disease, epidemiology in clinical practice, innovations in pancreatic cancer identification and management, HPV-related cancers, and the role of the gut microbiome.

Released: 18-Oct-2023 9:00 AM EDT
New “Guide to the Guidelines” Publication Offers Practical Advice for Implementing ACG Clinical Guidelines
American College of Gastroenterology (ACG)

This new publication, introduced at the ACG 2023 Annual Scientific Meeting, provides clinical vignettes to demonstrate the practical application of ACG Clinical Guidelines.

Released: 17-Oct-2023 5:05 PM EDT
Multi-drug resistant strain of E.coli battles bacteria in healthy gut
University of Birmingham

Different strains of E.coli can outcompete one another to take over the gut, a new study reveals.

Newswise: More Aggressive Treatment Doesn’t Impact Quality of Life for Metastatic Colorectal Cancer Patients, According to New Study in JNCCN
Released: 12-Oct-2023 10:00 AM EDT
More Aggressive Treatment Doesn’t Impact Quality of Life for Metastatic Colorectal Cancer Patients, According to New Study in JNCCN
National Comprehensive Cancer Network® (NCCN®)

New research in JNCCN finds that removing as much tumor as possible in multiorgan metastatic colorectal cancer—via various methods—did not cause a decrease in quality of life despite an increase in adverse events; survival benefits remain unclear.

Newswise: New Study Links Intestinal Glycan Modifications to Obesity and Inflammation
Released: 11-Oct-2023 5:00 PM EDT
New Study Links Intestinal Glycan Modifications to Obesity and Inflammation
Chiba University

Located in the mucus layer that lines the gastrointestinal tract, mucins—proteins with attached sugar molecules—play a key role in combating bacterial infection and providing a safe haven to friendly gut bacteria through unknown mechanisms.

Newswise: Hackensack Meridian JFK University Medical Center Welcomes Iman Andalib, MD, Advanced Practice Gastroenterologist
Released: 11-Oct-2023 11:05 AM EDT
Hackensack Meridian JFK University Medical Center Welcomes Iman Andalib, MD, Advanced Practice Gastroenterologist
Hackensack Meridian Health

Dr. Andalib uses the latest technological and treatment advances for complex and minimally invasive diagnostic and therapeutic procedures

Newswise: “Endoscopy: Pushing the Limits” Focus of October Special Issue of The American Journal of Gastroenterology
Released: 11-Oct-2023 9:00 AM EDT
“Endoscopy: Pushing the Limits” Focus of October Special Issue of The American Journal of Gastroenterology
American College of Gastroenterology (ACG)

The October special issue of The American Journal of Gastroenterology focuses on endoscopy, highlighting best practices, novel endoscopic techniques, practical guidance for endoscopic complications, and future opportunities.

Newswise: RESEARCH ALERT: New Insights Into the Gastrointestinal Tract
Released: 10-Oct-2023 12:05 PM EDT
RESEARCH ALERT: New Insights Into the Gastrointestinal Tract
Cedars-Sinai

By better understanding the cellular and molecular processes involved in mucus formation, scientists aim to uncover how to treat gastrointestinal-related diseases.

Newswise: World-first research breakthrough sparks new hope for bowel cancer patients
Released: 9-Oct-2023 3:05 AM EDT
World-first research breakthrough sparks new hope for bowel cancer patients
La Trobe University

Every year, over 15,500 Australians are diagnosed with bowel cancer, and it is the second leading cause of cancer deaths in the country. Over 1,700 (one in ten) of those diagnosed are young Australians aged under 50, and this incidence is increasing.

Newswise: Study validates pyrvinium as treatment to prevent stomach cancer
Released: 6-Oct-2023 11:05 AM EDT
Study validates pyrvinium as treatment to prevent stomach cancer
Vanderbilt University Medical Center

A study published Oct. 4 in further validates that pyrvinium, a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.

Newswise: Gut bacteria found in wild wolves may be key to improving domestic dogs’ health
Released: 4-Oct-2023 7:05 AM EDT
Gut bacteria found in wild wolves may be key to improving domestic dogs’ health
Oregon State University

Gut microbes found in wild wolves may be the key to alleviating a debilitating gastrointestinal condition common to domestic dogs, according to a study led by researchers at Oregon State University – Cascades.

Released: 2-Oct-2023 11:05 AM EDT
Joint IAFNS-USDA Webinar Series Tackles Gut Health, Immune Function
Institute for the Advancement of Food and Nutrition Sciences

Collaborative webinars to focus on key scientific trends and findings related to gut microbiome and nutrition, and the interaction of diet, stress and immune function.

Released: 29-Sep-2023 4:05 PM EDT
الداء البطني مقابل عدم تحمل الغلوتين: خبير مايو كلينك هيلثكير يوضح الفرق
Mayo Clinic

مع ازدياد خيارات الطعام الخالي من الغلوتين، قد يصعُب تقرير ما إذا كان يجب إضافة الغلوتين إلى نظامك الغذائي أم لا. يقول الدكتور سرمد سامي، بكالوريوس الطب والجراحة، طبيب الجهاز الهضمي في مايو كلينك هيلثكير في لندن، أنه لا توجد ضرورة بالنسبة لمعظم الأشخاص لاستبعاد الأطعمة التي تحتوي على الغلوتين بشكل كامل، إذ لا توجد فائدة صحية مثبتة من وراء ذلك. ويشرح الدكتور سامي في هذا التنبيه السبب ويوضح الفرق بين حالتين طبيتين متعلقتين بالغلوتين هما: الداء البطني وعدم تحمل الغلوتين.

Released: 29-Sep-2023 11:05 AM EDT
Doença celíaca versus intolerância ao glúten: especialista da Mayo Clinic Healthcare explica a diferença
Mayo Clinic

Ainda que as opções alimentares livres de glúten estejam aumentando, pode ser difícil tomar a decisão de incluir ou não o glúten na dieta. Para a maioria das pessoas, não existe a necessidade de eliminar completamente os alimentos que contenham glúten e não existem benefícios comprovados a partir da adoção dessa prática, explica o médico cirurgião Dr. Sarmed Sami, gastroenterologista na Mayo Clinic Healthcare em Londres.

Released: 29-Sep-2023 10:40 AM EDT
Celiaquía vs. intolerancia al gluten: un experto de Mayo Clinic Healthcare explica la diferencia
Mayo Clinic

A medida que aumentan las opciones de alimentos sin gluten, puede resultar difícil decidir incluirlo o no en la alimentación. Para la mayoría de las personas, no hay necesidad de eliminar por completo los alimentos que contienen gluten y no se ha demostrado ningún beneficio de hacerlo, afirma el Licenciado en Medicina y Cirugía, Sarmed Sami, gastroenterólogo de Mayo Clinic Healthcare en Londres.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Released: 26-Sep-2023 1:05 PM EDT
Coeliac disease vs gluten intolerance: Mayo Clinic Healthcare expert explains the difference
Mayo Clinic

As gluten-free food options increase, it can be difficult to decide whether to include gluten in your diet or not. For most people, there is no need to completely eliminate foods containing gluten and no proven benefit from doing so, says Sarmed Sami, MBChB, a gastroenterologist at Mayo Clinic Healthcare in London.

Newswise: Combating Crohn’s with comics
Released: 20-Sep-2023 10:00 AM EDT
Combating Crohn’s with comics
Michigan Medicine - University of Michigan

A teenage patient’s unique way of detailing his experience with Crohn’s disease

Newswise: Study Reveals Colon Tumor Location Matters for Metastatic Disease
Released: 19-Sep-2023 4:05 PM EDT
Study Reveals Colon Tumor Location Matters for Metastatic Disease
Yale Cancer Center/Smilow Cancer Hospital

Colon cancers that spread to the liver may be substantially different depending on the location of where cancerous cells originate, according to new research. The study led by Yale Cancer Center researchers at Yale School of Medicine and Yale School of Public Health provides insight into the unique biology of right-sided and left-sided tumors, which may impact treatment options and patient outcomes.

Released: 19-Sep-2023 9:25 AM EDT
Inflammatory Bowel Disease Linked to Atopic Dermatitis, Penn Medicine Research Finds
Perelman School of Medicine at the University of Pennsylvania

Adults with atopic dermatitis (AD) have a 34 percent increased risk of developing new-onset inflammatory bowel disease (IBD) compared with individuals who do not have the skin condition, and children have a 44 percent increased risk, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.

Not for public release

This news release is embargoed until 11-Sep-2023 5:00 PM EDT Released to reporters: 5-Sep-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-Sep-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-Sep-2023 11:05 AM EDT
ينشر باحثو مايو كلينك النتائج الرئيسية حول بروتينات الخلايا لتحديد فعالية العلاج المناعي لسرطان القولون
Mayo Clinic

روشستر، مينيسوتا — مركز مايو كلينك الشامل لعلاج السرطان حدد الباحثون النتائج الرئيسية التي يمكن أن تساعد الأطباء في التنبؤ بما إذا كان المريض مصابًا بسرطان المستقيم والقولون المتقدم سيستفيد من العلاج المناعي. نُشرت الدراسة في مجلة أبحاث السرطان السريرية كلينيكال كانسر ريسيرش Clinical Cancer Research وتُبرز إمكانية استخدام التحليل المكاني لبروتينات معينة كأداة تنبؤية لاختيار المرشحين المناسبين للعلاج المناعي بحصار PD-1 في سرطان القولون والمستقيم، ممّا يؤدي في النهاية إلى تحسين نتائج العلاج وتقليل الحاجة إلى العلاجات غير الضرورية.

Released: 7-Sep-2023 11:05 AM EDT
Investigadores de Mayo Clinic publican hallazgos clave sobre proteínas celulares para determinar la eficacia de la inmunoterapia contra el cáncer de colon
Mayo Clinic

Los investigadores del Centro Oncológico Integral de Mayo Clinic han identificado hallazgos clave que pueden ayudar a los médicos a predecir si un paciente con cáncer colorrectal avanzado se beneficiará de la inmunoterapia.

Released: 7-Sep-2023 11:05 AM EDT
Pesquisadores da Mayo Clinic publicam as principais descobertas sobre proteínas celulares para determinar a eficácia da imunoterapia para câncer de cólon
Mayo Clinic

Os pesquisadores do Centro de Câncer da Mayo Clinic identificaram as principais descobertas que podem ajudar médicos a prever se um paciente com câncer colorretal avançado será beneficiado com a imunoterapia.

Newswise: Liver-Associated and Age-Related Studies Included in the September Issue of AJG
Released: 7-Sep-2023 10:00 AM EDT
Liver-Associated and Age-Related Studies Included in the September Issue of AJG
American College of Gastroenterology (ACG)

Research updates in gastroenterology and hepatology from the September issue of The American Journal of Gastroenterology, the flagship journal of the American College of Gastroenterology.

Released: 6-Sep-2023 10:25 AM EDT
Third NIH Grant Moves Novel Anti-Diarrheal Vaccine Forward
College of Veterinary Medicine, University of Illinois Urbana-Champaign

Dr. Weiping Zhang, professor in the Department of Pathobiology, was recently awarded a five-year, $5.6 million R01 grant from the National Institutes of Health (NIH) to optimize a promising vaccine against enterotoxigenic Escherichia coli (ETEC).

Newswise: Intestinal bacteria release molecular ‘brake’ on weight gain
Released: 31-Aug-2023 12:05 PM EDT
Intestinal bacteria release molecular ‘brake’ on weight gain
UT Southwestern Medical Center

Bacteria that live in the intestines inhibit a molecule that limits the amount of fat absorbed, increasing weight gain in mice fed a high-sugar, high-fat diet, researchers from UT Southwestern Medical Center report. The findings, published in Science, could eventually lead to new ways to combat obesity, diabetes, and malnutrition – health problems that plague hundreds of millions worldwide.

Released: 31-Aug-2023 9:55 AM EDT
Mayo Clinic researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer
Mayo Clinic

Mayo Clinic Comprehensive Cancer Center researchers have identified key findings that can assist clinicians in predicting whether a patient with advanced colorectal cancer will benefit from immunotherapy.

Not for public release

This news release is embargoed until 28-Aug-2023 5:00 PM EDT Released to reporters: 22-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 28-Aug-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Aug-2023 11:30 AM EDT
Altis Biosystems Launches RepliGut® Planar InflammaScreen Services to Accelerate Drug Discovery for Inflammatory Bowel Diseases
Altis Biosystems

Altis Biosystems, a leader in developing innovative, in vitro cell-based model systems for drug discovery, announces the launch of RepliGut® Planar InflammaScreen™ Services.

Newswise: Mutations in blood stem cells can exacerbate colon cancer
21-Aug-2023 9:45 AM EDT
Mutations in blood stem cells can exacerbate colon cancer
The Rockefeller University Press

Researchers at the University of Florida College of Medicine have discovered how common age-related changes in the blood system can make certain colon cancers grow faster.

Released: 22-Aug-2023 5:10 PM EDT
AI can predict certain forms of esophageal and stomach cancer
Michigan Medicine - University of Michigan

AI can predict certain forms of esophageal and stomach cancer Michigan Medicine study says.

Newswise: Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
Released: 22-Aug-2023 12:00 PM EDT
Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
Wistar Institute

Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the journal mBio.

Newswise: New study will compare microbes on fresh produce from gardens versus supermarkets
Released: 21-Aug-2023 2:05 AM EDT
New study will compare microbes on fresh produce from gardens versus supermarkets
University of Oregon

New University of Oregon research will investigate how microbes found on produce affect the gut microbiome, and compare how those microbes differ between produce from a home garden versus those from the supermarket.

   
Released: 17-Aug-2023 4:15 PM EDT
Research gives new insights into fighting antimicrobial resistance
University of Nottingham

Cooking food thoroughly and avoiding some types of vegetables and salad during a course of antibiotic treatment could potentially reduce antibiotic resistance, by preventing bacteria carrying resistance genes getting into the gut, according to a new study.

Newswise: Sylvester Surgeon-Scientist Awarded Center’s First Department of Defense Grant to Study Pancreatic Cancer
Released: 17-Aug-2023 8:55 AM EDT
Sylvester Surgeon-Scientist Awarded Center’s First Department of Defense Grant to Study Pancreatic Cancer
Sylvester Comprehensive Cancer Center

Researchers with Sylvester Comprehensive Cancer Center have been awarded a three-year, $800,000 grant from the U.S. Department of Defense (DoD)’s Congressionally Directed Medical Research Program to target chemotherapy resistance in pancreatic cancer.

Released: 17-Aug-2023 8:45 AM EDT
Sylvester Comprehensive Cancer Center Tip Sheet - August 2023
Sylvester Comprehensive Cancer Center

New research shows blood cancers are often misdiagnosed, an NCI grant to develop a urine test for prostate cancer, a surgeon-scientist receives Sylvester’s first DoD grant to study pancreatic cancer, bolstering emergency preparedness for climate-driven disasters, and more are included in this month’s tip sheet .

Newswise: Beneficial bacteria sense gut mucus to stay in line
Released: 17-Aug-2023 5:00 AM EDT
Beneficial bacteria sense gut mucus to stay in line
University of Oregon

The findings point to possible mechanisms behind intestinal conditions like Crohn’s disease and ulcerative colitis, and also suggest avenues to develop more effective probiotics.

   
Released: 15-Aug-2023 12:45 PM EDT
New genetic relations between irritable bowel syndrome and psychiatric diseases discovered
University of Bergen

We have all felt the workings of the so called “brain-gut-axis”, how our intestines get affected, for example, by stress. But still, researchers don’t know a lot about the relation between our gut and our brain.

Released: 15-Aug-2023 12:00 PM EDT
American Dental Association Science & Research Institute Receives Grant to Study IBD Symptoms through Saliva Testing
American Dental Association (ADA)

The American Dental Association Science & Research Institute, in collaboration with the University of North Carolina Center for Gastrointestinal Biology and Disease, was recently awarded a $130,000 grant from the Crohn’s & Colitis Foundation.

Newswise: Innovative research on schistosomiasis-associated colorectal cancer (SA-CRC) yields unique insights into genetic mutations and treatment implications
Released: 15-Aug-2023 10:05 AM EDT
Innovative research on schistosomiasis-associated colorectal cancer (SA-CRC) yields unique insights into genetic mutations and treatment implications
Chinese Academy of Sciences

A new genomic study conducted by researchers on schistosomiasis-associated colorectal cancer (SA-CRC) provides critical insights into the unique mutational landscape and the potential treatment pathways for the disease. SA-CRC, linked to chronic inflammation caused by schistosomal ova deposition in the intestine, presents different epidemiological and clinical outcomes than sporadic colorectal cancer (S-CRC).

Newswise: In battle against pancreatic cancer, grant-funded H-FIRE study offers hope
Released: 14-Aug-2023 2:05 PM EDT
In battle against pancreatic cancer, grant-funded H-FIRE study offers hope
Virginia Tech

The National Institutes of Health has awarded $2.6 million to a Virginia Tech team over five years for a study of high frequency irreversible electroporation (H-FIRE) for tumor ablation and immune system activation in cases of pancreatic cancer.

Released: 11-Aug-2023 9:00 AM EDT
GI Multi-Society Statement Regarding GLP-1 Agonists and Endoscopy
American College of Gastroenterology (ACG)

AASLD, ACG, AGA, ASGE and NASPGHAN recognize that the new class of GLP-1 receptor agonist may be associated with delayed gastric emptying and encourage our anesthesiology, endocrinology, and industry partners to work collaboratively with our members to develop the necessary evidence to appropriately inform medication adjustments prior to elective endoscopy.



close
1.32381